Wuhan General Group (China), Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WUHN research report →
Price Chart
About the company
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands.
- CEO
- Jeff Robinson
- IPO
- 2006
- Employees
- 700
- HQ
- Reno, NV, US
Get TickerSpark's AI analysis on WUHN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.55K
- P/E
- -0.01
- PEG
- -0.00
- P/S
- 1.17
- P/B
- 0.03
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 9.70%
- Op Margin
- -11882.90%
- Net Margin
- -12086.93%
- ROE
- -316.07%
- ROIC
- -254.74%
Latest fiscal year · YoY change
- Revenue
- $14.18K-57.4%
- Gross Profit
- $1.38K-92.1%
- Op Income
- $-1,684,520
- Net Income
- $-1,713,443-517.9%
- EPS
- $-0.03-494.9%
- OCF Growth
- -3251.2%
- FCF Growth
- -3251.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.21
- RSI (14)
- 59
- Avg Volume
- 1.90K
No earnings-call transcripts are available for WUHN yet.
- Free Float
- 73.6%
- Shares Outstanding
- 55.15M
- Float Shares
- 40.61M
Our WUHN coverage
Recent articles, reports, and earnings notes.
No research on WUHN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WUHN report →Head-To-Head Review: Xometry (NASDAQ:XMTR) versus Wuhan General Group (OTCMKTS:WUHN)
defenseworld.net · Apr 19
Financial Contrast: Middleby (NASDAQ:MIDD) vs. Wuhan General Group (OTCMKTS:WUHN)
defenseworld.net · Feb 9
Wuhan General Group (OTCMKTS:WUHN) vs. Standex International (NYSE:SXI) Head-To-Head Comparison
defenseworld.net · Nov 5
The Future Of Personalized Medicine For Mental Illness by Dr. Riyad Domingo
accesswire.com · Sep 23
Medspresso Announces Additional Speciality Coffees To The Range
accesswire.com · Sep 17
M2Bio Sciences Appoints Dr. Riyad Domingo as Chief Innovation Officer
accesswire.com · Sep 2
Dr. AnnaRx(TM) Launching CBD & CBN Nutraceutical Line
accesswire.com · Aug 24
Dr. Southey and Dr. Zarrebini Join M2Bio Sciences and Establish M2Bio Blockchain Research and Technology Group
accesswire.com · Aug 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.